Cargando…

Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study

BACKGROUND: Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, You-Bin, Han, Kyungdo, Kim, Bongsung, Lee, Seung-Eun, Jun, Ji Eun, Ahn, Jiyeon, Kim, Gyuri, Jin, Sang-Man, Kim, Jae Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858684/
https://www.ncbi.nlm.nih.gov/pubmed/31733656
http://dx.doi.org/10.1186/s12933-019-0953-7
_version_ 1783471003485077504
author Lee, You-Bin
Han, Kyungdo
Kim, Bongsung
Lee, Seung-Eun
Jun, Ji Eun
Ahn, Jiyeon
Kim, Gyuri
Jin, Sang-Man
Kim, Jae Hyeon
author_facet Lee, You-Bin
Han, Kyungdo
Kim, Bongsung
Lee, Seung-Eun
Jun, Ji Eun
Ahn, Jiyeon
Kim, Gyuri
Jin, Sang-Man
Kim, Jae Hyeon
author_sort Lee, You-Bin
collection PubMed
description BACKGROUND: Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 diabetes and subjects without diabetes. Furthermore, information about the hazard of cardiovascular disease and early mortality among Asians with type 1 diabetes is sparse, although the clinical and epidemiological characteristics of Asians with type 1 diabetes are unlike those of Europeans. We estimated the hazard of myocardial infarction (MI), hospitalization for heart failure (HF), atrial fibrillation (AF), and mortality during follow-up in Korean adults with type 1 diabetes compared with those without diabetes and those with type 2 diabetes. METHODS: We used Korean National Health Insurance Service datasets of preventive health check-ups from 2009 to 2016 in this retrospective longitudinal study. The hazard ratios of MI, HF, AF, and mortality during follow-up were analyzed using the Cox regression analyses according to the presence and type of diabetes in ≥ 20-year-old individuals without baseline cardiovascular disease (N = 20,423,051). The presence and type of diabetes was determined based on the presence of type 1 or type 2 diabetes at baseline. RESULTS: During more than 93,300,000 person-years of follow-up, there were 116,649 MIs, 135,532 AF cases, 125,997 hospitalizations for HF, and 344,516 deaths. The fully-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MI, hospitalized HF, AF, and all-cause death within the mean follow-up of 4.6 years were higher in the type 1 diabetes group than the type 2 diabetes [HR (95% CI) 1.679 (1.490–1.893) for MI; 2.105 (1.901–2.330) for HF; 1.608 (1.411–1.833) for AF; 1.884 (1.762–2.013) for death] and non-diabetes groups [HR (95% CI) 2.411 (2.138–2.718) for MI; 3.024 (2.730–3.350) for HF; 1.748 (1.534–1.993) for AF; 2.874 (2.689–3.073) for death]. CONCLUSIONS: In Korea, the presence of diabetes was associated with a higher hazard of cardiovascular disease and all-cause death. Specifically, people with type 1 diabetes had a higher hazard of cardiovascular disease and all-cause mortality compared to people with type 2 diabetes.
format Online
Article
Text
id pubmed-6858684
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68586842019-11-29 Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study Lee, You-Bin Han, Kyungdo Kim, Bongsung Lee, Seung-Eun Jun, Ji Eun Ahn, Jiyeon Kim, Gyuri Jin, Sang-Man Kim, Jae Hyeon Cardiovasc Diabetol Original Investigation BACKGROUND: Both type 1 and type 2 diabetes are well-established risk factors for cardiovascular disease and early mortality. However, few studies have directly compared the hazards of cardiovascular outcomes and premature death among people with type 1 diabetes to those among people with type 2 diabetes and subjects without diabetes. Furthermore, information about the hazard of cardiovascular disease and early mortality among Asians with type 1 diabetes is sparse, although the clinical and epidemiological characteristics of Asians with type 1 diabetes are unlike those of Europeans. We estimated the hazard of myocardial infarction (MI), hospitalization for heart failure (HF), atrial fibrillation (AF), and mortality during follow-up in Korean adults with type 1 diabetes compared with those without diabetes and those with type 2 diabetes. METHODS: We used Korean National Health Insurance Service datasets of preventive health check-ups from 2009 to 2016 in this retrospective longitudinal study. The hazard ratios of MI, HF, AF, and mortality during follow-up were analyzed using the Cox regression analyses according to the presence and type of diabetes in ≥ 20-year-old individuals without baseline cardiovascular disease (N = 20,423,051). The presence and type of diabetes was determined based on the presence of type 1 or type 2 diabetes at baseline. RESULTS: During more than 93,300,000 person-years of follow-up, there were 116,649 MIs, 135,532 AF cases, 125,997 hospitalizations for HF, and 344,516 deaths. The fully-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MI, hospitalized HF, AF, and all-cause death within the mean follow-up of 4.6 years were higher in the type 1 diabetes group than the type 2 diabetes [HR (95% CI) 1.679 (1.490–1.893) for MI; 2.105 (1.901–2.330) for HF; 1.608 (1.411–1.833) for AF; 1.884 (1.762–2.013) for death] and non-diabetes groups [HR (95% CI) 2.411 (2.138–2.718) for MI; 3.024 (2.730–3.350) for HF; 1.748 (1.534–1.993) for AF; 2.874 (2.689–3.073) for death]. CONCLUSIONS: In Korea, the presence of diabetes was associated with a higher hazard of cardiovascular disease and all-cause death. Specifically, people with type 1 diabetes had a higher hazard of cardiovascular disease and all-cause mortality compared to people with type 2 diabetes. BioMed Central 2019-11-16 /pmc/articles/PMC6858684/ /pubmed/31733656 http://dx.doi.org/10.1186/s12933-019-0953-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Lee, You-Bin
Han, Kyungdo
Kim, Bongsung
Lee, Seung-Eun
Jun, Ji Eun
Ahn, Jiyeon
Kim, Gyuri
Jin, Sang-Man
Kim, Jae Hyeon
Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
title Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
title_full Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
title_fullStr Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
title_full_unstemmed Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
title_short Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
title_sort risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858684/
https://www.ncbi.nlm.nih.gov/pubmed/31733656
http://dx.doi.org/10.1186/s12933-019-0953-7
work_keys_str_mv AT leeyoubin riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT hankyungdo riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT kimbongsung riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT leeseungeun riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT junjieun riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT ahnjiyeon riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT kimgyuri riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT jinsangman riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy
AT kimjaehyeon riskofearlymortalityandcardiovasculardiseaseintype1diabetesacomparisonwithtype2diabetesanationwidestudy